Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Ablexis, LLC logo — A superior, next generation transgenic platform.

Ablexis, LLC

A superior, next generation transgenic platform.

Founded 2009 United States San Diego, United States 1 employees Series A Total: $12.00M Biotechnology, Health Care +1

General Information

Company Name Ablexis, LLC
Founded Year 2009
Location United States San Diego, United States
Employees 1
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Ablexis, LLC. To contact Ablexis, LLC, visit ablexis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Ablexis, LLC

Ablexis, LLC is a biotechnology startup that offers the AlivaMab® Mouse platform, a suite of transgenic mouse strains designed for human therapeutic antibody discovery. The platform is tailored for various applications across antibody drug discovery, including the development of highest quality IgGs, single-domain VH, multispecifics, ADCs, CARs, TCRm, and other modalities. The AlivaMab Mouse strains are highly regarded for their ability to generate drug-like antibodies with broad combinatorial and somatic diversities, high affinities, specificity, and excellent developability properties. The company was founded in 2009 and is based in the United States. Ablexis, LLC received a significant $12.00M Series A investment on 02 June 2010 from Third Rock Ventures and Pfizer Venture Investments. The company's clients include major pharmas, public and private biotechs, and leading academic institutions, and the derived antibodies are utilized in clinical development across various formats. Additionally, the company's sister entity, AlivaMab Biologics, provides services in antibody drug discovery, engineering, and protein sciences. For those interested in licensing the AlivaMab Mouse, they may reach out to [email protected] or visit the company's website at www.ablexis.com for further information.

Taxonomy: transgenic platform, antibody discovery, pharmaceuticals, biopharmaceuticals, monoclonal antibodies, drug discovery, therapeutic antibodies, biotech, antibody engineering, protein sciences

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $12.00M 2
Third Rock Ventures
Third Rock Ventures, Pfizer Venture Investments
02 Jun 2010

Ablexis, LLC Alternatives & Competitors

Ablexis, LLC vs
ElsaLys Biotech
ElsaLys Biotech

A frontrunner in therapeutic monoclonal antibody development secures €2.1m in its inaugural financin...

Series A
Biotechnology, Health Care
Ablexis, LLC vs
MSM Protein Technologies, Inc.
MSM Protein Technologies, Inc.

Pioneering novel methods for precise targeting of challenging therapeutic proteins in drug discovery...

Seed
5 employees
Biotechnology, Health Care
Ablexis, LLC vs
ADC Biotechnology
ADC Biotechnology

Accelerating solutions for developers to overcome conjugation challenges, making new ADC-based anti-...

Venture round
Biopharma, Biotechnology

FAQ About Ablexis, LLC

A superior, next generation transgenic platform.
Ablexis, LLC was founded in 2009.
Ablexis, LLC is headquartered in San Diego, United States.
Ablexis, LLC operates in Biotechnology, Health Care and Medical Devices. Its work centres on transgenic platform, antibody discovery, pharmaceuticals and biopharmaceuticals.
Ablexis, LLC has approximately 1 employees.
Ablexis, LLC has completed 1 funding round, raising a total of $12.00M. The latest funding stage is Series A.
Top alternatives and competitors to Ablexis, LLC include ElsaLys Biotech, MSM Protein Technologies, Inc., ADC Biotechnology, Bright Biologics, RevMAb Biosciences USA, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ablexis, LLC and ElsaLys Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ablexis, LLC, https://bouncewatch.com/company/ablexis-llc, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes